文献速递妇科

腹腔镜根治性子宫切除术对FIGO IB期宫颈癌患者生存结局的影响:韩国两家医疗机构医院的匹配研究

Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in Korea.
PubMed 文献 · Gynecol Oncol · 2019-08-02

该回顾性匹配队列研究比较了2000至2018年间两家三级医院中343例腹腔镜根治性子宫切除术(LRH)与222例开腹根治性子宫切除术(ORH)的FIGO IB期宫颈癌患者。匹配后LRH组无进展生存(PFS)较差(3年:85.4% vs 91.8%;P=0.036),总生存无显著差异。在IB1期且肿瘤≤2cm的匹配患者中,两种术式的PFS和OS相似。

要点

  • 匹配后LRH组3年PFS为85.4%,低于ORH组的91.8%(P=0.036)。
  • 匹配后两组总生存无显著差异,盆腔、腹膜后淋巴结、腹部复发及远处转移发生率无显著差异。
  • IB1期且肿瘤≤2cm的匹配患者中,LRH与ORH的PFS和OS相似。

核心结论

  • 尽管为回顾性设计,该匹配队列研究提示ORH可能更适合FIGO IB期宫颈癌的手术治疗。
  • 在IB1期且肿瘤≤2cm的患者中,LRH可能适用,因为无论手术方式如何,结局相当。
  • 需要进一步的前瞻性研究。

研究设计与样本

  • 回顾性识别2000至2018年间在两家三级医疗机构医院接受LRH(n=343)或ORH(n=222)的FIGO IB1-IB2期宫颈癌患者。
  • 采用基于马氏距离的样本匹配对分期、组织学、宫颈肿块大小、宫旁浸润和淋巴结转移进行混杂调整。
  • 通过独立匹配过程,研究人群缩小至IB1期患者及术前MRI肿瘤大小≤2cm的IB1期患者。

主要发现

  • 匹配后LRH组无进展生存(PFS)较ORH组差(3年:85.4% vs 91.8%;P=0.036)。
  • 匹配后两组总生存(OS)无显著差异。
  • 两组盆腔复发、腹膜后淋巴结复发、腹部复发及远处转移发生率无显著差异。
  • 在IB1期且宫颈肿块大小≤2cm的匹配患者中,LRH组与ORH组PFS相似(3年:90.0% vs 93.1%;P=0.8)。
  • 在IB1期且宫颈肿块大小≤2cm的匹配患者中,LRH组与ORH组OS相似(5年:98.6% vs 96.4%;P=0.6)。

临床怎么用

  • 作者认为ORH可能更适合FIGO IB期宫颈癌的手术治疗。
  • 作者认为在IB1期且肿瘤≤2cm的患者中,LRH可能适用,因为无论手术方式如何,结局相当。
  • 作者提出需要进一步的前瞻性研究。

局限性

  • 原文指出研究为回顾性设计。
  • 原文结论提出需要进一步的前瞻性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare survival outcomes of primary laparoscopic radical hysterectomy (LRH) and open radical hysterectomy (ORH) in patients with FIGO stage IB cervical cancer. METHODS: We retrospectively identified stage IB1-IB2 cervical cancer patients who received either LRH (n = 343) or ORH (n = 222) at two tertiary institutional hospitals between 2000 and 2018. To adjust for confounders, we conducted Mahalanobis distance-based sample matching for stage, histology, cervical mass size, parametrial invasion, and lymph node metastasis. Then, survival outcomes were compared between the matched groups. Through the independent matching processes, we narrowed the study population to stage IB1 patients and stage IB1 patients with tumor size ≤2 cm on pre-operative MRI. RESULTS: After matching, LRH group showed poorer progression-free survival (PFS) than ORH group (3-year: 85.4% vs. 91.8%; P = 0.036), whereas no significant difference in overall survival (OS) was found. Regarding recurrence patterns, no significant differences in the incidences of pelvic, retroperitoneal lymph node and abdominal recurrences, or distant metastasis were observed between the two groups. Among the matched patients with stage IB1 who had cervical mass size ≤2 cm, the LRH and ORH groups showed similar PFS (3-year: 90.0% vs. 93.1%; P = 0.8) and OS (5-year: 98.6% vs. 96.4%; P = 0.6). CONCLUSIONS: Despite the retrospective design, our matched cohort study suggests that ORH might be preferable for the surgical treatment of FIGO stage IB cervical cancer. However, in stage IB1 patients with tumor size ≤2 cm, LRH might be applicable, as equivalent outcomes were found regardless of the surgical approach. Further prospective studies are warranted.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Kim SI, Lee M, Lee S, et al. Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in Korea. Gynecol Oncol. 2019. PMID: 31383569. doi:10.1016/j.ygyno.2019.07.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。